Combination of amlodipine besylate and olmesartan medoxomil provides greater reduction in blood pressure compared with monotherapy in subjects with and without diabetes

被引：0

作者：

Bakris, G. ^{[1
]}

Karki, S. ^{[2
]}

Lee, J. ^{[2
]}

Heyrman, R. ^{[2
]}

机构：

[1] Univ Chicago, Sch Med, Chicago, IL 60637 USA

[2] Daiichi Sankyo Inc, Parsippany, NJ USA

来源：

JOURNAL OF HYPERTENSION | 2008年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：S190 / S190

页数：1

共 50 条

[21] Use of 24-hour ambulatory blood pressure monitoring (ABPM) to assess antihypertensive efficacy: A comparison of olmesartan medoxomil (OLM) and amlodipine besylate (AML)
Marbury, TC
Silfani, TN
AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 68A - 68A
[22] Blood Pressure Reduction in fixed-dose Combination of Olmesartan/Amlodipine in Patients on Candesartan Monotherapy with inadequately controlled Blood Pressure - Results of Studies SEVICONTROL 1 & 2
Bramlage, P.
Zemmrich, C.
Gansz, A.
Nadal, J.
Plate, K.
Wolf, W.
Lueders, S.
INTERNIST, 2013, 54 : 109 - 110
[23] New data confirm the predominant reduction in blood pressure values in diabetes patients through Twynsta compared to amlodipine monotherapy
Homolka, Inge
JOURNAL FUR HYPERTONIE, 2011, 15 (03): : 48 - 49
[24] The combination of olmesartan medoxomil and Amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study
Chrysant, Steven G.
Melino, Michael
Karki, Sulekha
Lee, James
Heyrman, Reinilde
CLINICAL THERAPEUTICS, 2008, 30 (04) : 587 - 604
[25] Aliskiren/Valsartan Combination Provides Greater 24-Hour Blood Pressure Lowering Compared With Valsartan Monotherapy In Hypertensive Patients
Giles, Thomas D.
Alessi, Thomas
Purkayastha, Das
Zappe, Dion
HYPERTENSION, 2011, 58 (05) : E81 - E81
[26] Olmesartan medoxomil lowers blood pressure as rapidly as amlodipine besylate in patients with mild to moderate hypertension: Results of a randomized, double-blind, placebo-controlled study
Chrysant, S
Wang, A
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 102A - 102A
[27] COMBINATION ALISKIREN plus AMLODIPINE PROVIDES GREATER BLOOD PRESSURE REDUCTION THAN AMLODIPINE ALONE IN AFRICAN AMERICANS WITH STAGE 2 HYPERTENSION AND OBESITY OR METABOLIC SYNDROME
Weinberger, M.
Izzo, J.
Purkayastha, D.
Lee, J.
Israel, M.
Hilkert, R.
Black, H.
JOURNAL OF HYPERTENSION, 2010, 28 : E100 - E100
[28] Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes
White, William B.
Cuadra, Rene H.
Lloyd, Eric
Bakris, George L.
Kupfer, Stuart
JOURNAL OF HYPERTENSION, 2016, 34 (04) : 788 - 797
[29] The Fixed-Dose Combination of Olmesartan/Amlodipine Was Superior in Central Aortic Blood Pressure Reduction Compared with Perindopril/Amlodipine: A Randomized, Double-Blind Trial in Patients with Hypertension
Luis Ruilope
Angie Schaefer
Advances in Therapy, 2013, 30 : 1086 - 1099
[30] Fixed-Combination Olmesartan/Amlodipine Was Superior to Perindopril plus Amlodipine in Reducing Central Systolic Blood Pressure in Hypertensive Patients With Diabetes
Ruilope, Luis M.
JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (06): : 528 - 535

← 1 2 3 4 5 →